Dapirolizumab

1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Dapirolizumab is a PEG-free antigen-binding (Fab') fragment that binds CD40L (CD154) and lacks a functional Fc domain. Dapirolizumab inhibits CD40L-dependent immune responses without causing thrombotic complications and can be used in research related to systemic lupus erythematosus.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : 99.66%
  • CAS. Nr.: 2235418-88-7
  • Molecular Weight:145.5 kDa
  • Speicherung:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00